‹
›
This content requires a premium subscription.
Please
log in
or
subscribe
to continue.
Journal of Clinical Oncology (JCO) Podcast
Glembatumumab Vedotin (CDX-011, CR011-vcMMAE): On The Brink Of Targeted Therapy For Triple-Negative Breast Cancer?
30
00:00:00
/ 00:11:47
30